http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010146948-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate | 2009-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010146948-A |
| titleOfInvention | IRON AND ZINC-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATING IRON DEFICIENCY |
| abstract | 1. The pharmaceutical composition for use in the prevention and treatment of iron deficiency and iron deficiency anemia, characterized by a content of from 3 to 12 mg / ml of iron, from 1 to 12 mg / ml of zinc and from 1.5 to 36 mg / ml of vitamin C as active agent. ! 2. The composition according to claim 1, characterized by an additional content of from 0.015 to 0.3 mg / ml of folic acid. ! 3. The composition according to claims 1 and 2, where the amount of iron is in the range from 5 to 10 mg / ml, zinc in the range from 4 to 9 mg / ml, vitamin C in the range from 5 to 30 mg / ml and folic acid ranges from 0.08 to 0.25 mg / ml. ! 4. The composition according to claims 1 and 2, where the amount of iron is in the range from 7 to 9 mg / ml, zinc in the range from 5 to 7 mg / ml, vitamin C in the range from 10 to 20 mg / ml and folic acid ranges from 0.1 to 0.2 mg / ml. ! 5. The composition according to claim 1, additionally containing fructose, preferably in an amount of from 30 to 300 mg / ml, more preferably in an amount of from 100 to 200 mg / ml, and most preferably in an amount of from 120 to 180 mg / ml. ! 6. The composition of claim 1, further comprising citric acid, preferably in an amount of from 1.5 to 600 mg / ml, more preferably in an amount of from 50 to 300 mg / ml, and most preferably in an amount of from 90 to 110 mg / ml. ! 7. The composition according to claim 1, characterized in that the iron is included in the composition in the form of an iron salt selected from the group consisting of ferrous fumarate, ferruginous gluconate, ferruginous succinate, ferrous glutamate, ferruginous lactate, ferrous citrate, ferrous tartrate, ferrous pyrophosphate . ! 8. The composition according to claim 1, characterized in that the iron is included in the composition in the form of a complex of iron selected from the group consisting of iron-EDTA, orth |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109730323-A |
| priorityDate | 2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.